Why Eli Lilly’s Stock Surge Is Captivating Long-Term Investors
Eli Lilly and Company’s stock has surged by 593% over five years, illustrating remarkable market interest and performance. In just one week, Eli Lilly increased its market cap by $25 billion, attracting significant attention from investors. The company’s average annual earnings per
